DrugInformer Search

Dilacor Xr

Average User Review Score
* Based on 0 reviews from across the web.

Diltiazem (INN) (/dɪlˈtaɪəzɛm/) is a nondihydropyridines (non-DHP) calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia. It relaxes the smooth muscles in the walls of arteries, which opens (dilates) the arteries, allows blood to flow more easily, and lowers blood pressure. Additionally, it lowers blood pressure by acting on the heart itself to reduce the rate, strength, and conduction speed of each beat.

Read more on Wikipedia

  Please use Workbench for in-depth research on Dilacor Xr.

* Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients.

Tell us about your Experience with Dilacor Xr

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: Blood pressure decreased

Posted By Verwon in prescriptiondrug-info.com on July 28, 2007 @ 12:00 am

This is Dilatazem120mgs, a generic for Dilacor XR. Used to help lower blood pressure.

Druginformer Identified Side Effects: None

Posted By robo in drugs.com on May 24, 2005 @ 12:00 am

Exactly right This pill is DILTIAZEM HCL ER 240 MG a generic version of Dilacor XR® Imprint Code MYLAN 5340 / MYLAN 5340 Description light blue/flesh colored capsule You will fi...

Druginformer Identified Side Effects: None

Posted By stingray in drugs.com on February 2, 2005 @ 12:00 am

U.S. Group Warns of Mix-Ups with Foreign Drugs U.S. Group Warns of Mix-Ups with Foreign Drugs Thu Jan 27, 2005 06:38 PM ET WASHINGTON (Reuters) - The same brand names are sometimes used for di...

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.